Post–COVID-19 Symptoms and Conditions Among Children and Adolescents — United States, March 1, 2020–January 31, 2022

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Personal Author:
  Kompaniyets, Lyudmyla ; Bull-Otterson, Lara ; Boehmer, Tegan K. ; Baca, Sarah ; Alvarez, Pablo ; Hong, Kai ; Hsu, Joy ; Harris, Aaron M. ; Gundlapalli, Adi V. ; Saydah, Sharon
• Description:
  Post-COVID-19 (post-COVID) symptoms and conditions* are new, recurring, or ongoing health problems that occur 4 or more weeks after infection with SARS-CoV-2 (the virus that causes COVID-19). Previous studies have characterized and estimated the incidence of post-COVID conditions among adults (1,2), but data among children and adolescents are limited (3-8). Using a large medical claims database, CDC assessed nine potential post-COVID signs and symptoms (symptoms) and 15 potential post-COVID conditions among 781,419 U.S. children and adolescents aged 0-17 years with laboratory-confirmed COVID-19 (patients with COVID-19) compared with 2,344,257 U.S. children and adolescents without recognized COVID-19 (patients without COVID-19) during March 1, 2020-January 31, 2022. The analysis identified several symptoms and conditions with elevated adjusted hazard ratios among patients with COVID-19 (compared with those without). The highest hazard ratios were recorded for acute pulmonary embolism (adjusted hazard ratio [aHR] = 2.01), myocarditis and cardiomyopathy (1.99), venous thromboembolic event (1.87), acute and unspecified renal failure (1.32), and type 1 diabetes (1.23), all of which were rare or uncommon in this study population. Conversely, symptoms and conditions that were most common in this study population had lower aHRs (near or below 1.0). Patients with COVID-19 were less likely than were patients without to experience respiratory signs and symptoms, symptoms of mental conditions, muscle disorders, neurological conditions, anxiety and fear-related disorders, mood disorders, and sleeping disorders. COVID-19 prevention strategies, including vaccination for all eligible children and adolescents, are critical to prevent SARS-CoV-2 infection and subsequent illness, including post-COVID symptoms and conditions (9).
• Subjects:
  Adolescent Adult Child COVID-19 Humans Incidence Laboratories Nervous System Diseases SARS-CoV-2
• Source:
  MMWR Morbidity Mortal Weekly Rep. 71(31):993-999
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• DOI:
  http://dx.doi.org/10.15585/mmwr.mm7131a3
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  35925799
• Pubmed Central ID:
  PMC9368731
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Pages in Document:
  7 pdf pages
• Volume:
  71
• Issue:
  31
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:3e025f4831c54ec6fa5a30ced0eb232faeb598762184c462cfb3292a6f97be5b276b31009badf59eadb902bb478525b281d85a46b0c57fd1fc3bf758c5fec457
• Download URL:
  https://stacks.cdc.gov/view/cdc/120655/cdc_120655_DS1.pdf
• File Type:
  [PDF - 311.72 KB ]